甲状旁腺切除术与口服西那卡塞对腹膜透析患者骨密度的影响:PROCEED 先导随机试验
本研究为前瞻性开放标签随机试验,纳入65例维持性腹膜透析合并晚期继发性甲状旁腺功能亢进症(SHPT)患者,比较全甲状旁腺切除术+前臂自体移植与口服西那卡塞治疗12个月对骨密度(BMD)的影响。结果显示两种治疗均显著改善腰椎和股骨颈BMD,但手术组改善幅度大于西那卡塞组(P<0.001);手术组股骨颈和腰椎骨量减少/骨质疏松比例下降更明显,而两组桡骨远端BMD均无显著变化。
要点
- 腹膜透析合并晚期SHPT患者骨量减少/骨质疏松患病率高。
- 甲状旁腺切除术在改善腰椎和股骨颈BMD方面优于西那卡塞。
- 两种治疗对桡骨远端BMD均无显著改善。
核心结论
- 腹膜透析合并晚期SHPT患者中骨密度降低及骨量减少/骨质疏松比例较高。
- 全甲状旁腺切除术在12个月时增加腰椎和股骨颈BMD及降低骨量减少/骨质疏松比例方面优于口服西那卡塞。
- 两种干预对桡骨远端BMD均无显著改变。
研究设计与样本
- 前瞻性先导性开放标签随机试验。
- 纳入65例来自香港2所大学附属医院的维持性腹膜透析合并晚期SHPT患者。
- 干预为全甲状旁腺切除术加前臂自体移植对比口服西那卡塞治疗12个月。
主要发现
- 甲状旁腺切除术组和西那卡塞组腰椎及股骨颈BMD在12个月内均显著改善,手术组改善幅度大于西那卡塞组(P<0.001)。
- 股骨颈T值分类为骨量减少/骨质疏松的比例:手术组从78.2%降至51.7%(P<0.001),西那卡塞组从65.7%降至52.0%(P=0.7)。
- 腰椎T值分类为骨量减少/骨质疏松的比例:手术组从53.1%降至31.0%(P=0.01),西那卡塞组从59.4%降至53.8%(P=0.3)。
- 两组桡骨远端BMD的T值或z值在12个月内均无显著变化。
临床怎么用
- 对于腹膜透析合并晚期SHPT且骨密度低的患者,甲状旁腺切除术可能比西那卡塞更有效改善腰椎和股骨颈BMD。
- 临床决策需结合患者个体情况,并注意两种治疗对桡骨远端BMD均无显著获益。
局限性
- 未评估骨组织学。
- 研究持续时间为12个月。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE & OBJECTIVE: Parathyroidectomy and calcimimetics have been used to reduce fracture risk in patients with kidney failure and advanced secondary hyperparathyroidism (SHPT), but direct comparisons of these treatment approaches have not been implemented. This pilot study compared their effects on bone mineral density (BMD) in this patient population. STUDY DESIGN: A prospective pilot open-label randomized trial. SETTING & PARTICIPANTS: 65 patients receiving maintenance peritoneal dialysis with advanced SHPT recruited from 2 university-affiliated hospitals in Hong Kong. INTERVENTIONS: Total parathyroidectomy with forearm autografting versus oral cinacalcet treatment for 12 months. OUTCOME: Prespecified secondary end points including changes in BMD z and T scores of femoral neck, lumbar spine, and distal radius 12 months after treatment initiation and also categorized as osteopenia or osteoporosis according to the World Health Organization. RESULTS: Both total parathyroidectomy and cinacalcet significantly improved BMD of the lumbar spine and femoral neck over 12 months, but the total parathyroidectomy group had a greater increase than the cinacalcet-treated group (P<0.001). The proportion of study participants classified as having osteopenia/osteoporosis by femoral neck T-score fell from 78.2% to 51.7% in the total parathyroidectomy group (P<0.001) and from 65.7% to 52.0% in cinacalcet-treated group after 12 months (P=0.7). The proportion of participants with a T-score at the lumbar spine classified as osteopenia/osteoporosis fell from 53.1% to 31.0% in the total parathyroidectomy group (P=0.01) and from 59.4% to 53.8% with cinacalcet (P=0.3). No significant change was observed in BMD T or z score of the distal radius over 12 months with either intervention. LIMITATIONS: Bone histology was not assessed, and the study duration was 12 months. CONCLUSIONS: A large proportion of peritoneal dialysis patients with advanced SHPT had low bone densities and osteopenia/osteoporosis. Total parathyroidectomy increased the BMD of the lumbar spine and femoral neck and reduced osteopenia/osteoporosis more than oral cinacalcet. FUNDING: Grants from academic (The University of Hong Kong Research) and not-for-profit (Hong Kong Society of Nephrology) entities. REGISTRATION: Registered at Clinicaltrials.gov with study number NCT01447368. PLAIN-LANGUAGE SUMMARY: It is not known whether oral cinacalcet and surgical parathyroidectomy differ in their effects on bone parameters in patients with advanced secondary hyperparathyroidism (SHPT) receiving peritoneal dialysis. This pilot randomized trial evaluated the effect of medical versus surgical therapy on bone mineral densities (BMD) as prespecified secondary study end points. The findings showed that a large proportion of peritoneal dialysis patients with advanced SHPT had low bone densities and osteopenia/osteoporosis. Parathyroidectomy increased the BMD of the lumbar spine and femoral neck more than cinacalcet over 12 months. Parathyroidectomy reduced the proportion of patients with osteopenia/osteoporosis at the lumbar spine and femoral neck more than cinacalcet after 12 months. Neither intervention led to an increase in the BMD of the distal radius over 12 months.
引用
- Wang AY, Tang TK, Yau YY, et al. Impact of Parathyroidectomy Versus Oral Cinacalcet on Bone Mineral Density in Patients on Peritoneal Dialysis With Advanced Secondary Hyperparathyroidism: The PROCEED Pilot Randomized Trial. Am J Kidney Dis. 2023. PMID: 38040277. doi:10.1053/j.ajkd.2023.10.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。